ANT BIO Official Article: p-Tau217 in Alzheimer’s Disease – Literature Review & Product Empowerment

Brand: ANT BIO PTE. LTD.

Document Type: Literature Analysis & Knowledge Popularization

Full English, Academic, Original

Part 1: Literature Analysis Format

1. Literature Information

This literature focuses on the molecular characteristics, pathological mechanisms, and clinical translational value of p‑Tau217 as a core biomarker for Alzheimer’s disease (AD). It systematically elucidates the specificity, early warning potential, and broad application prospects of p‑Tau217 in AD diagnosis, differential diagnosis, disease monitoring, and therapeutic evaluation.

2. Research Background

Alzheimer’s disease is a progressive neurodegenerative disorder with insidious onset and long preclinical course. Traditional diagnostic methods rely on clinical symptoms, CSF examination, or PET imaging, which are invasive, costly, or poorly accessible. There is an urgent need for highly specific, minimally invasive, and early‑stage biomarkers to achieve early screening, accurate typing, and dynamic monitoring of AD.

3. Research Idea

This study aims to:

1. Clarify the molecular structure and post‑translational modification characteristics of p‑Tau217.
2. Explore its pathological mechanism and specificity in AD.
3. Establish standardized and ultrasensitive detection methods for p‑Tau217.
4. Verify its clinical value in early diagnosis, differential diagnosis, and efficacy evaluation.
5. Provide a reliable biomarker system for translational research of AD drugs.

4. Research Results

1. p‑Tau217 shows extremely high specificity for AD and can effectively distinguish AD from other tauopathies and dementias.
2. p‑Tau217 increases significantly in the preclinical stage of AD, decades earlier than clinical symptoms.
3. Ultrasensitive detection technology enables accurate quantification of p‑Tau217 in plasma.
4. p‑Tau217 is closely correlated with the degree of tau lesions in the brain and can be used for disease staging and prognosis evaluation.
5. p‑Tau217 can serve as an early indicator for monitoring the efficacy of anti‑Aβ and anti‑tau drugs.

5. Product Empowerment (ANT BIO)

ANT BIO PTE. LTD. provides a full set of high‑performance reagents to support the above research.

Specific functions:

• Provide highly specific antibodies that accurately recognize the phosphorylated epitope of p‑Tau217.
• Provide matched ELISA kits for rapid and quantitative detection of p‑Tau217.
• Provide recombinant proteins as standards and quality controls.
• Provide universal buffers and diluents to ensure stability and repeatability of detection.
• Support the establishment of standardized detection systems and promote clinical translation.

6. Brand Mission

ANT BIO PTE. LTD. is a professional supplier of life science reagents. We focus on providing high‑quality antibodies, proteins, kits, and universal reagents for global researchers. Our three sub‑brands:

• Absin: Supplies universal reagents and kits.
• Starter: Supplies high‑performance antibodies.
• UA: Supplies recombinant proteins.

We are committed to empowering scientific research and promoting medical progress through stable, reliable, and high‑quality products.

7. Related Product List

1. Anti-p-Tau217 specific antibody (Starter)
2. Human p-Tau217 ELISA Kit (Absin)
3. Recombinant p-Tau217 protein (UA)
4. Universal antibody diluent (Absin)
5. ELISA plate washing solution (Absin)
6. Protein quantitative standard product (Absin)

Part 2: Knowledge Popularization Format

1. Concept

p‑Tau217 refers to the tau protein phosphorylated at threonine 217. As a core phosphorylated tau biomarker, it has extremely high specificity for Alzheimer’s disease and has become a revolutionary tool for early diagnosis and pathological research of AD.

2. Research Frontier

1. p‑Tau217 is a core biomarker in the 2024 NIA‑AA AD diagnostic criteria.
2. Plasma p‑Tau217 detection has reached fg‑level ultrasensitivity, realizing non‑invasive early screening.
3. p‑Tau217 can accurately distinguish AD from other tauopathies and dementias.
4. p‑Tau217 is closely related to the pathological process of AD and can be used for dynamic monitoring.
5. Immunotherapy targeting p‑Tau217 has become a new direction for AD disease‑modifying treatment.

3. Research Significance

1. Realize early, non‑invasive, and accurate screening of AD.
2. Improve the accuracy of differential diagnosis of neurodegenerative diseases.
3. Provide dynamic indicators for evaluating the efficacy of AD drugs.
4. Promote the translational research of AD early intervention and precision medicine.
5. Provide strong support for population screening and public health policies for the elderly.

4. Related Mechanisms and Product Applications

p‑Tau217 is produced by the abnormal phosphorylation of tau protein under the action of kinases such as GSK‑3β and CDK5. It detaches from microtubules, forms neurofibrillary tangles, and leads to neuronal degeneration.

ANT BIO products support:

• Specific identification and quantification of p‑Tau217.
• Establishment of standardized detection systems.
• Basic research and clinical sample detection.
• Drug screening and efficacy evaluation.

5. Brand Mission

ANT BIO PTE. LTD. is a professional supplier of life science reagents. We focus on providing high‑quality antibodies, proteins, kits, and universal reagents for global researchers. Our three sub‑brands:

• Absin: Supplies universal reagents and kits.
• Starter: Supplies high‑performance antibodies.
• UA: Supplies recombinant proteins.

We are committed to empowering scientific research and promoting medical progress through stable, reliable, and high‑quality products.

6. Related Product List

1. Anti-p-Tau217 specific antibody (Starter)
2. Human p-Tau217 ELISA Kit (Absin)
3. Recombinant p-Tau217 protein (UA)
4. Universal antibody diluent (Absin)
5. ELISA supporting reagents (Absin)
6. Protein quantitative standard (Absin)

Brand Promotion Copy

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights